CN105477012B - 一种左乙拉西坦氯化钠注射液组合物及其制备方法 - Google Patents
一种左乙拉西坦氯化钠注射液组合物及其制备方法 Download PDFInfo
- Publication number
- CN105477012B CN105477012B CN201510929932.9A CN201510929932A CN105477012B CN 105477012 B CN105477012 B CN 105477012B CN 201510929932 A CN201510929932 A CN 201510929932A CN 105477012 B CN105477012 B CN 105477012B
- Authority
- CN
- China
- Prior art keywords
- sodium chloride
- levetiracetam
- chloride injection
- composition
- follows
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Abstract
Description
500mg:100ml | 1000mg:100ml | 1500mg:100ml | |
左乙拉西坦 | 500mg | 1000mg | 1500mg |
氯化钠 | 820mg | 750mg | 540mg |
三水醋酸钠 | 164mg | 164mg | 164mg |
冰醋酸 | 5.5mg | 6.5mg | 7.5mg |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510929932.9A CN105477012B (zh) | 2015-12-15 | 2015-12-15 | 一种左乙拉西坦氯化钠注射液组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510929932.9A CN105477012B (zh) | 2015-12-15 | 2015-12-15 | 一种左乙拉西坦氯化钠注射液组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105477012A CN105477012A (zh) | 2016-04-13 |
CN105477012B true CN105477012B (zh) | 2018-08-17 |
Family
ID=55664527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510929932.9A Active CN105477012B (zh) | 2015-12-15 | 2015-12-15 | 一种左乙拉西坦氯化钠注射液组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105477012B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021028838A1 (en) * | 2019-08-14 | 2021-02-18 | Sintetica S.A. | Intrathecal administration of levetiracetam |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107913247A (zh) * | 2016-10-10 | 2018-04-17 | 北京阜康仁生物制药科技有限公司 | 一种左乙拉西坦注射用制剂及其制备方法 |
CN107913245A (zh) * | 2016-10-10 | 2018-04-17 | 北京阜康仁生物制药科技有限公司 | 一种左乙拉西坦氯化钠注射液的制备方法 |
CN107213114A (zh) * | 2017-05-19 | 2017-09-29 | 万特制药(海南)有限公司 | 一种含有左乙拉西坦药物组合物的注射剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550143A (zh) * | 2013-10-19 | 2014-02-05 | 浙江华海药业股份有限公司 | 一种左乙拉西坦注射液的制备方法 |
CN103690477A (zh) * | 2013-04-23 | 2014-04-02 | 南京正科制药有限公司 | 一种左乙拉西坦注射液 |
EP2878296A1 (en) * | 2013-11-29 | 2015-06-03 | UCB Pharma GmbH | Pharmaceutical composition comprising lacosamide and levetiracetam |
CN104906585A (zh) * | 2015-05-23 | 2015-09-16 | 河北仁合益康药业有限公司 | 一种奥拉西坦大容量注射液组合物及其制备方法 |
-
2015
- 2015-12-15 CN CN201510929932.9A patent/CN105477012B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690477A (zh) * | 2013-04-23 | 2014-04-02 | 南京正科制药有限公司 | 一种左乙拉西坦注射液 |
CN103550143A (zh) * | 2013-10-19 | 2014-02-05 | 浙江华海药业股份有限公司 | 一种左乙拉西坦注射液的制备方法 |
EP2878296A1 (en) * | 2013-11-29 | 2015-06-03 | UCB Pharma GmbH | Pharmaceutical composition comprising lacosamide and levetiracetam |
CN104906585A (zh) * | 2015-05-23 | 2015-09-16 | 河北仁合益康药业有限公司 | 一种奥拉西坦大容量注射液组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021028838A1 (en) * | 2019-08-14 | 2021-02-18 | Sintetica S.A. | Intrathecal administration of levetiracetam |
Also Published As
Publication number | Publication date |
---|---|
CN105477012A (zh) | 2016-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105477012B (zh) | 一种左乙拉西坦氯化钠注射液组合物及其制备方法 | |
CN102552127B (zh) | 一种奥硝唑注射液 | |
TWI238719B (en) | Moxifloxacin/sodium chloride formulation | |
CN105412007B (zh) | 一种左乙拉西坦氯化钠注射液组合物及其制备方法 | |
CN102626409B (zh) | 一种含18种氨基酸的药物组合物 | |
CN105125485A (zh) | 一种提高葛根素药物注射制剂稳定性注射药物的制备方法 | |
CN101933922B (zh) | 一种含抗氧化剂的氨基酸组合物 | |
CN107412152B (zh) | 一种盐酸右美托咪定注射液组合物 | |
CN105434339A (zh) | 一种左乙拉西坦氯化钠注射液组合物及其制备方法 | |
WO2021012686A1 (zh) | 盐酸纳洛酮注射液及其制备方法 | |
CN102949339B (zh) | 一种含有罗库溴铵的注射剂 | |
CN102836123A (zh) | 一种含有左乙拉西坦活性成分的注射剂及其制备工艺 | |
CN106943346A (zh) | 甲地高辛液体制剂、其制备方法及其用途 | |
CN105963247A (zh) | 一种提高槲皮素药物注射制剂稳定性注射药物的制备方法 | |
CN103989640B (zh) | 奥硝唑静脉给药制剂及其制备方法 | |
CN100998585A (zh) | 一种盐酸甲氯芬酯注射液的制剂及其制备方法 | |
CN106361969A (zh) | 一种提高参麦药物注射制剂稳定性药物组合物的制备方法 | |
CN102166185A (zh) | 等渗纳洛酮注射液及其制备方法 | |
CN111067864A (zh) | 一种盐酸罗哌卡因氯化钠注射液及制备方法 | |
CN103202805A (zh) | 一种含有长春西汀的注射用药物组合物及其制备方法 | |
CN102600139B (zh) | 一种含20种氨基酸的药物组合物 | |
CN104721223B (zh) | 一种复方电解质的注射液药物组合物及其制备方法 | |
CN102727427A (zh) | 等渗纳洛酮注射液及其制备方法 | |
CN104027304B (zh) | 胞磷胆碱钠葡萄糖注射液 | |
CN102727429B (zh) | 改善稳定性的匹多莫德注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 051500 Haixing Road, Zhaoxian County Industrial Park, Shijiazhuang, Hebei Applicant after: HEBEI RENHE YIKANG PHARMACEUTICAL Co.,Ltd. Address before: 053411 Hengshui City, Hebei, Wuyi County, Qing Liang store town Applicant before: HEBEI RENHE YIKANG PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190415 Address after: 050000 Building 309, Hongchang Science and Technology Industrial Park, 100m south of the junction of Yangtze River Avenue and Hengshan Street, Yuhua District, Shijiazhuang City, Hebei Province Patentee after: Shijiazhuang Development Zone Boxin Medical Technology Development Co.,Ltd. Address before: 051500 Haixing Road, Zhaoxian County Industrial Park, Shijiazhuang, Hebei Patentee before: HEBEI RENHE YIKANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230427 Address after: 051530 No. 7, Haixing Road, industrial park, xinzhaidian Town, Zhao county, Shijiazhuang City, Hebei Province Patentee after: Renhe Yikang Group Co.,Ltd. Address before: 050000 Building 309, Hongchang Science and Technology Industrial Park, 100m south of the junction of Yangtze River Avenue and Hengshan Street, Yuhua District, Shijiazhuang City, Hebei Province Patentee before: Shijiazhuang Development Zone Boxin Medical Technology Development Co.,Ltd. |